Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Hepatol Commun. 2022 Jan;6(1):120-132. doi: 10.1002/hep4.1696. Epub 2021 Jun 17.
Hepatol Commun. 2022.
PMID: 34558835
Free PMC article.
Clinical Trial.